Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.
about
Dystrophic epidermolysis bullosa: a reviewPrevalence of specific anti-skin autoantibodies in a cohort of patients with inherited epidermolysis bullosa.Effects of the Nd:YAG 1320-nm laser on skin rejuvenation: clinical and histological correlations.Multiple minimally invasive Erbium: Yttrium Aluminum Garnet laser mini-peels for skin rejuvenation: an objective assessment.Efficacy of mesotherapy in facial rejuvenation: a histological and immunohistochemical evaluation.Evaluating Clinical Use of a Ceramide-dominant, Physiologic Lipid-based Topical Emulsion for Atopic Dermatitis.Transcriptome and ultrastructural changes in dystrophic Epidermolysis bullosa resemble skin aging.Losartan ameliorates dystrophic epidermolysis bullosa and uncovers new disease mechanismsEffects of a skin-massaging device on the ex-vivo expression of human dermis proteins and in-vivo facial wrinkles.Novel molecular therapies for heritable skin disordersPrioritization of therapy uncertainties in Dystrophic Epidermolysis Bullosa: where should research direct to? an example of priority setting partnership in very rare disorders.Site-specific genome editing for correction of induced pluripotent stem cells derived from dominant dystrophic epidermolysis bullosa.An incompletely penetrant novel mutation in COL7A1 causes epidermolysis bullosa pruriginosa and dominant dystrophic epidermolysis bullosa phenotypes in an extended kindredCase Report: Whole exome sequencing reveals a novel frameshift deletion mutation p.G2254fs in COL7A1 associated with autosomal recessive dystrophic epidermolysis bullosa.The extracellular matrix of the dermis: flexible structures with dynamic functions.Epidermolysis bullosa acquisita.Treatment of hereditary epidermolysis bullosa: updates and future prospects.Inherited blistering skin diseases: underlying molecular mechanisms and emerging therapies.Molecular architecture and function of the hemidesmosome.Molecular architecture and function of the hemidesmosome.Recessive dystrophic epidermolysis bullosa: a review of disease pathogenesis and update on future therapies.Next generation human skin constructs as advanced tools for drug development.A novel deletion and two recurrent substitutions on type VII collagen gene in seven Iranian patients with epidermolysis bullosa.High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa.Chitinases and Imaginal disc growth factors organize the extracellular matrix formation at barrier tissues in insects.Electro-optical Synergy Technique: A New and Effective Nonablative Approach to Skin Aging.Microneedling Therapy for Atrophic Acne Scars: An Objective Evaluation.Serum levels of anti-type VII collagen antibodies detected by enzyme-linked immunosorbent assay in patients with epidermolysis bullosa acquisita are correlated with the severity of skin lesions.Anchoring fibril formationForehead wrinkles: a histological and immunohistochemical evaluation.Combinatorial omics analysis reveals perturbed lysosomal homeostasis in collagen VII-deficient keratinocytes.Serum levels of high mobility group box 1 correlate with disease severity in recessive dystrophic epidermolysis bullosa.Multiple microneedling sessions for minimally invasive facial rejuvenation: an objective assessment.Ex Vivo COL7A1 Correction for Recessive Dystrophic Epidermolysis Bullosa Using CRISPR/Cas9 and Homology-Directed Repair
P2860
Q28084871-44E8F038-6C4B-458D-802D-4CDA3BF9A259Q33589020-294BA0C8-6F43-4A12-A677-C6BB6694B315Q33910330-F95DD406-5F48-4CDE-A855-90A8C3C4F8D3Q34294215-0BA7A4DD-882D-4521-955B-A4723FF1DFB8Q34334421-F5AAAB6E-1C7C-499E-8126-7895C6B4D522Q34760244-A41CB563-A379-4F79-95F9-BBE3E5AEFB9BQ35859768-49E92A21-B604-4C73-B8F4-843EB1D9CABAQ36057596-318274E9-83DF-44AE-87AC-2EA2EE5AA37EQ36294141-03EBCDC9-AA84-4FD8-8391-0928EF26F1B2Q36610899-25A011FB-132C-4D92-A974-28B40878DD67Q36797935-1BEB2BF1-E0BA-42B2-B6A6-FEA1EA1F6F70Q36930948-F0B35A8D-12F5-4E66-A758-F1CF4B6CD56FQ37005427-C680B1E4-B75B-4B5E-9F43-007E24568B23Q37051455-85991A2E-7477-489F-8F66-4F199A9F5BB2Q37880196-0F4D21EE-E684-4A13-B979-691BEAA3B1BBQ38078021-F4018F9F-B425-46FF-B5A1-54DF7A61D54BQ38176832-80E98D49-FD29-4E05-BCE1-F074B9C10DD5Q38180485-3E48FEB8-EC10-4764-92D7-C673A9799112Q38285370-3B6DBD90-F16C-4D56-9B7A-F1FE3DC31C38Q38504833-471EEF83-9274-42B6-8AC9-BDB8565802E9Q38510204-B5047742-B5D1-44DF-92A0-8DD5919FEC05Q38673576-6E7F80F2-937C-4B57-9C1F-910E081F4F43Q38811015-EE4FBCB3-8343-4F14-A66A-AC9701841493Q39789694-4C6B9E09-B39B-46E0-A5A5-77F0BEB774DDQ40029900-A7A8205E-1B63-4132-9EE7-B442EB27E222Q41576218-F7419348-7108-4078-98DF-CE48114B59E5Q42245973-C4C8A6E9-8FC1-44D5-A19F-09ECFCDA6A07Q43616075-3285B0DB-FE10-4118-ADB2-1CE82374D9EDQ45316737-EFE2BDE6-36EB-4C92-B61B-27A2F84A4FE9Q46317818-90FCF7A3-DA08-4A38-916E-68A0780A4099Q50078076-51DE11A4-09F1-4BD1-B3D8-73F9FE41F05CQ50957880-64DC5E45-1FD4-4E45-9DC8-A1FB7420FDFDQ52661210-0A113BFF-4A0B-4F34-8408-83E86BA05A6AQ57159704-F9C8F05C-0763-4873-AD43-5EE388BDF797
P2860
Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Type VII collagen: the anchori ...... trophic epidermolysis bullosa.
@en
Type VII collagen: the anchori ...... trophic epidermolysis bullosa.
@nl
type
label
Type VII collagen: the anchori ...... trophic epidermolysis bullosa.
@en
Type VII collagen: the anchori ...... trophic epidermolysis bullosa.
@nl
prefLabel
Type VII collagen: the anchori ...... trophic epidermolysis bullosa.
@en
Type VII collagen: the anchori ...... trophic epidermolysis bullosa.
@nl
P2860
P1433
P1476
Type VII collagen: the anchori ...... trophic epidermolysis bullosa.
@en
P2093
Hye Jin Chung
P2860
P304
P356
10.1016/J.DET.2009.10.011
P50
P577
2010-01-01T00:00:00Z